Lenalidomide Is Effective Treating Patients With Relapsed Multiple Myeloma and Very Severe Renal Impairment

被引:0
|
作者
Joao, Cristina M.
Gomes, Fernando
Geraldes, Catarina
Parreira, Joana Maria
Neves, Manuel L.
Coelho, Ines
Esteves, Susana
Esteves, Graca V.
机构
关键词
D O I
10.1182/blood.V122.21.5401.5401
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5401
引用
收藏
页数:2
相关论文
共 50 条
  • [21] An alternative dosing strategy of lenalidomide for patients with relapsed multiple myeloma
    Popat, Rakesh
    Khan, Iftekhar
    Dickson, Jenny
    Cheesman, Simon
    Smith, Dean
    D'Sa, Shirley
    Rabin, Neil
    Yong, Kwee
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (01) : 148 - 151
  • [22] Lenalidomide in Combination with Dexamethasone in Elderly Patients with Advanced, Relapsed or Refractory Multiple Myeloma and Renal Failure
    Tosi, Patrizia
    Gamberi, Barbara
    Castagnari, Barbara
    Molinari, Anna Lia
    Savini, Paolo
    Ceccolini, Michela
    Tani, Monica
    Merli, Anna
    Imola, Manuela
    Mianulli, Anna Maria
    Cellini, Claudia
    Tomassetti, Simona
    Merli, Francesco
    Fattori, Pierpaolo
    Zaccaria, Alfonso
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2013, 5 (01): : 1 - 5
  • [23] Pomalidomide, bortezomib, and dexamethasone (PVd) in lenalidomide (LEN)-pretreated relapsed refractory multiple myeloma: Subanalysis of patients with renal impairment in OPTIMISMM.
    Schjesvold, Fredrik
    Dimopoulos, Meletios A.
    Beksac, Meral
    Oriol, Albert
    Lindsay, Jindriska
    Liberati, Anna Marina
    Galli, Monica
    Robak, Pawel
    Weisel, Katja
    Larocca, Alessandra
    Yagci, Munci
    Vural, Filiz
    Anderson, Larry D., Jr.
    Kanate, Abraham Sebastian
    Mendez, Eva Casal
    Jiang, Ruiyun
    Srinivasan, Shankar
    Grote, Lara
    Biyukov, Tsvetan Nikolov
    Richardson, Paul G.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [24] Gemcitabine in Treating Patients with Refractory or Relapsed Multiple Myeloma
    Zheng, Hua
    Yang, Fan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (21) : 9291 - 9293
  • [25] Desensitization to Lenalidomide in a Patient With Relapsed Multiple Myeloma
    Seki, Jack T.
    Banglawala, Sabiha
    Lentz, Emily M.
    Reece, Donna E.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (02): : 162 - 165
  • [26] Spotlight on Lenalidomide in Relapsed or Refractory Multiple Myeloma
    Lesley J. Scott
    Katherine A. Lyseng-Williamson
    BioDrugs, 2011, 25 : 333 - 337
  • [27] Lenalidomide for the treatment of relapsed or refractory multiple myeloma
    Weber, D. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 22 - 24
  • [28] Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
    Stewart, A. Keith
    Rajkumar, S. Vincent
    Dimopoulos, Meletios A.
    Masszi, Tamas
    Spicka, Ivan
    Oriol, Albert
    Hajek, Roman
    Rosinol, Laura
    Siegel, David S.
    Mihaylov, Georgi G.
    Goranova-Marinova, Vesselina
    Rajnics, Peter
    Suvorov, Aleksandr
    Niesvizky, Ruben
    Jakubowiak, Andrzej J.
    San-Miguel, Jesus F.
    Ludwig, Heinz
    Wang, Michael
    Maisnar, Vladimr
    Minarik, Jiri
    Bensinger, William I.
    Mateos, Maria-Victoria
    Ben-Yehuda, Dina
    Kukreti, Vishal
    Zojwalla, Naseem
    Tonda, Margaret E.
    Yang, Xinqun
    Xing, Biao
    Moreau, Philippe
    Palumbo, Antonio
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (02): : 142 - 152
  • [29] Spotlight on Lenalidomide in Relapsed or Refractory Multiple Myeloma
    Scott, Lesley J.
    Lyseng-Williamson, Katherine A.
    BIODRUGS, 2011, 25 (05) : 333 - 337
  • [30] The efficacy and safety of lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma patients with impaired renal function
    Weber, D. M.
    Spencer, A.
    Wang, M.
    Chen, C.
    Attal, M.
    Niesvizky, R.
    Prince, M.
    Yu, Z.
    Knight, R.
    Dimopoulos, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)